Clinical Trial Update: Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 PK/PD comparison of Mayne Glucagon for Injection versus Glucagen in healthy volunteers to characterize pharmacokinetics and pharmacodynamics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia

Drugs mentioned

• GlucaGen (glucagon)
• Mayne Glucagon for Injection (glucagon)

Snippet

Sponsor: Hospira, now a wholly owned subsidiary of Pfizer | Conditions: Hypoglycemia | Phase 1 | Status: COMPLETED